  The pathology of Alzheimer's disease (AD) and mild cognitive impairment (MCI)
is characterized by the presence of beta-amyloid extracellular plaques and
neurofibrillary tangles containing hyper-phosphorylated tau. Individuals
carrying the apolipoprotein E-e4 (APOE-e4) allele are at increased risk of
cognitive decline and developing AD pathology. The development of positron
emission tomography (PET) radioligands sensitive to tau neurofibrillary
tangles, such as 18F-AV1451, has allowed for visualization and assessment of AD
pathology in vivo. The radioligand used in 18F-AV1451 binds with iron in
addition to tau neurofibrillary tangles. We employ multimodal neuroimaging
analyses, combining iron-sensitive measures from MRI with 18F-AV1451 PET, to
examine off-target binding effects in cohorts of 20 APOE-e4 negative, 20
APOE-e4 positive MCI, and 29 control participants. Increased tau pathology,
after controlling for tissue susceptibility, was found in the temporal lobe and
hippocampus of APOE-e4+ MCI participants as compared to APOE-e4 negative MCI
and control participants. Tau pathology in the hippocampus was significantly
related to memory, but only in APOE-e4+ participants. Correlations between
hippocampal 18F-AV1451 PET uptake and cognitive correlations did not
significantly differ when correcting for the influence of iron on 18F-AV1451
PET signal. However, controlling for susceptibility was found to influence
correlations between tau-PET uptake and diffusion metrics and the change in
this interaction may be due to the influence of iron on diffusivity. Taken
together, these results suggest that iron does not need to be accounted for in
group comparisons of tau-PET uptake or correlations between cognitive measures
and tau-PET SUVR. However, iron should be taken into account in correlations
between diffusion measures and tau-PET uptake.
